![Steen Meier Rønborg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steen Meier Rønborg
Corporate Officer/Principal at University of Copenhagen
Steen Meier Rønborg active positions
Companies | Position | Start | End |
---|---|---|---|
University of Copenhagen | Corporate Officer/Principal | 03/07/2009 | - |
Career history of Steen Meier Rønborg
Former positions of Steen Meier Rønborg
Companies | Position | Start | End |
---|---|---|---|
Alsensa ApS
![]() Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market. | Chief Administrative Officer | 15/04/2010 | 28/06/2012 |
Director/Board Member | 02/07/2009 | 15/04/2010 | |
Chief Tech/Sci/R&D Officer | 01/10/2000 | 02/07/2009 | |
Founder | 15/04/2010 | 15/04/2010 | |
President | 01/10/2000 | 02/07/2009 |
Training of Steen Meier Rønborg
University of Copenhagen | Doctorate Degree |
Statistics
International
Denmark | 3 |
Operational
Chief Administrative Officer | 1 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Alsensa ApS
![]() Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market. | Commercial Services |
- Stock Market
- Insiders
- Steen Meier Rønborg
- Experience